Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The prevalence of low 25-hydroxyvitamin D3 levels was significantly (p < 0.00001) higher in the tinnitus group (53.2%) compared to the control group (31.7%).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Levels of 25-hydroxyvitamin D3 in individuals with primary subjective tinnitus and their associations with tinnitus occurrence and severity
Study design awaiting verification · Frontiers in Neurology · 2026
Original publication title
Levels of 25-hydroxyvitamin D3 in individuals with primary subjective tinnitus and their associations with tinnitus occurrence and severity
Copyright © 2026 Molnár, Mavrogeni, Mavrogenis and Maihoub.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This study aimed to analyze vitamin D3 levels in both a tinnitus group and a control group.
Source: ObjectiveAbstract: What methods does the paper describe?
A total of 350 patients with primary subjective tinnitus and 347 participants serving as a control group were examined. All patients underwent an otorhinolaryngological examination, audiological testing, and laboratory testing, including measurements of 25-hydroxyvitamin D3 levels.
Source: Materials and methodsAbstract: Results
The prevalence of low 25-hydroxyvitamin D3 levels was significantly (p < 0.00001) higher in the tinnitus group (53.2%) compared to the control group (31.7%). Furthermore, when comparing the specific levels of 25-hydroxyvitamin D3 between the tinnitus and control groups, a statistically significant difference was observed (p < 0.00001), with lower levels found in the tinnitus group. Additionally, according to a logistic regression model, lower levels of 25-hydroxyvitamin D3 significantly predicted the occurrence of tinnitus (p = 0.000; OR: 0.132, 95% CI = 0.066 to 0.264).
Additionally, it was found to be associated with moderately severe and severe tinnitus (p = 0.021; OR: 1.800, 95% CI = 0.806 to 4.022) and the development of chronic tinnitus (p = 0.001; OR: 0.717, 95% CI = 0.384 to 1.340). Moreover, ROC analysis indicated that lower levels of 25-hydroxyvitamin D3 are significant predictors of tinnitus (p = 0.000, 95% CI = 0.702 to 0.815), showing a sensitivity of 75.8%.
Source: ResultsAbstract: Conclusion
The notably lower levels of 25-hydroxyvitamin D3 suggest its potential role in the development of tinnitus. Additionally, proper supplementation of vitamin D3 could lead to new therapeutic approaches for managing tinnitus.
Source: ConclusionAuthors’ abstract
Objective
This study aimed to analyze vitamin D3 levels in both a tinnitus group and a control group.
Materials and methods
A total of 350 patients with primary subjective tinnitus and 347 participants serving as a control group were examined. All patients underwent an otorhinolaryngological examination, audiological testing, and laboratory testing, including measurements of 25-hydroxyvitamin D3 levels.
Results
The prevalence of low 25-hydroxyvitamin D3 levels was significantly (p < 0.00001) higher in the tinnitus group (53.2%) compared to the control group (31.7%). Furthermore, when comparing the specific levels of 25-hydroxyvitamin D3 between the tinnitus and control groups, a statistically significant difference was observed (p < 0.00001), with lower levels found in the tinnitus group. Additionally, according to a logistic regression model, lower levels of 25-hydroxyvitamin D3 significantly predicted the occurrence of tinnitus (p = 0.000; OR: 0.132, 95% CI = 0.066 to 0.264).
Additionally, it was found to be associated with moderately severe and severe tinnitus (p = 0.021; OR: 1.800, 95% CI = 0.806 to 4.022) and the development of chronic tinnitus (p = 0.001; OR: 0.717, 95% CI = 0.384 to 1.340). Moreover, ROC analysis indicated that lower levels of 25-hydroxyvitamin D3 are significant predictors of tinnitus (p = 0.000, 95% CI = 0.702 to 0.815), showing a sensitivity of 75.8%.
Conclusion
The notably lower levels of 25-hydroxyvitamin D3 suggest its potential role in the development of tinnitus. Additionally, proper supplementation of vitamin D3 could lead to new therapeutic approaches for managing tinnitus.
Publication and source details
Original title: Levels of 25-hydroxyvitamin D3 in individuals with primary subjective tinnitus and their associations with tinnitus occurrence and severity
András Molnár; Panayiota Mavrogeni; Aphrodite Mavrogenis; Stefani Maihoub
Frontiers in Neurology · 2026
* Correspondence: András Molnár, andrasm94@gmail.comCopyright © 2026 Molnár, Mavrogeni, Mavrogenis and Maihoub.2026Molnár, Mavrogeni, Mavrogenis and Maihoubhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:22:19.769039+00:00
DOI: 10.3389/fneur.2025.1751366 · PMC12832500